Senior Product Manager | Marketing
- Employer
- Scilex Holding Company
- Location
- Palo Alto, CA
- Start date
- Oct 16, 2024
View more categoriesView less categories
- Discipline
- Marketing, Product Development/Management
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Biotech Bay
Job Details
Salary Range: $187,000 - $209,000
The role may be remote (with once per month travel to headquarters) or local, based at our Palo Alto, CA headquarters (hybrid, on-site 3 days per week). Salary may vary depending on whether remote or local.
The pay range for this position is expected to be between $187,000 - $209,000/annually; however, the base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills and experience. The total compensation package for this position also includes medical benefits, 401(k) eligibility, vacation, sick time, and parental leave. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment.
If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other payment or compensation program) at any time, including reasons related to individual performance, Company or individual department/team performance, and market factors.
Scilex Holding Company’s pay range data is provided in accordance with local state pay transparency regulations. Scilex Holding Company may post different minimum wage ranges for permanent residency petitions pursuant to US Department of Labor requirements.
Scilex Holding Company is committed to equal employment opportunities, and a workplace that embraces diversity and inclusion for qualified individuals of all backgrounds.
About Scilex
SCILEX HOLDING COMPANY (Nasdaq: SCLX, “Scilex”), is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.
The company’s lead product ZTlido® (lidocaine topical system) 1.8%, is a marketed prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain. ZTlido® possesses novel delivery and adhesion technology designed to address many of the limitations of current prescription lidocaine patches by providing significantly improved adhesion and continuous pain relief throughout the 12-hour administration period. Click here for ZTLido’s Important Safety Information and US Prescribing Information.
We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYBTM, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. We launched ELYXYBTM in the U.S. in April 2023 and are planning to commercialize GLOPERBA in 2024.
Our three product candidates are (i) SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (“SEMDEXATM”), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica and has received Fast Track Status from the FDA. Currently there is no FDA approved non-opioid epidural injection to treat lumbosacral radicular pain, or sciatica; (ii) SP-103 (lidocaine topical system) 5.4%, (“SP-103”), a Phase 2, next-generation, triple-strength formulation of ZTlido, for the treatment of low back pain (“LBP”) and has received Fast Track Status from the FDA; and (iii) SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (“SP-104”), a novel low-dose delayed-release naltrexone hydrochloride being developed for the treatment of fibromyalgia. If these product candidates are approved by the FDA, we believe each of them could become the treatment option for their respective indications in the United States.
SCILEX is committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them the most. Scilex Pharmaceuticals and Semnur Pharmaceuticals are wholly-owned subsidiaries of Scilex Holding Company.
If you’re a high-energy, compassionate, and collaborative individual with a strong desire to make a difference in patient’s lives, we encourage you to consider joining the Scilex Holding team!
The Senior Product Manager – Marketing will be responsible for the development and implementation of the brand plan for a Migraine asset, with a high priority being finalizing optimal Positioning, Messaging and Implementation for release at the National Sales Meeting in March 2025. The key areas of emphasis for this role are personal promotion, non-personal promotion, and omnichannel promotion – spanning strategy development and tactical execution.
Must have relevant Pharmaceutical/Biotech Marketing experience.
This position will report into the Head of Marketing and work in collaboration with cross-functional team members, including field sales.
The role is based at our Palo Alto, CA headquarters (hybrid, on-site 3 days per week).
Role and Responsibilites
- Market research
- Build and optimize the Strategic Marketing/Brad plan.
- Drive execution of the Tactical plan while ensuring consistency with brand strategy
- Lead HCP facing marketing efforts for: personal promotion (i.e. field sales facing), non-personal promotion (such as speakers’ bureau) and omnichannel (direct marketing).
- Lead Patient facing marketing efforts, where warranted.
- Partnering with Medical, a key internal stakeholder, on aligning the Medical and Marketing plans. Lead Medical Education activities, eg KOL engagement and advisory boards.
- Partnering with Sales and Sales Training – key internal stakeholders to develop POAs with.
- Partnering with the Market Access team to align the Access and Marketing plans. Develop the PVP.
- Manage partner agency relationships, workflow, and related expense budgets.
- Partner with internal analytics team and external partners to define metrics and analyze performance of marketing programs.
- Ensure legal/regulatory compliance and medical accuracy of all marketing materials.
Qualifications and Education Requirements
- Bachelor’s degree. MBA a plus.
- Migraine/Neurology experience a plus, but not mandatory.
- 5-10 years of relevant Pharmaceutical/Biotech experience in Product Marketing is required. Sales/Market Research experience can be a complement, but not a substitute for this.
- Excellent interpersonal and communication skills.
- Demonstrated track record of success in a cross-functional and collaborative environment.
Preferred Skills
- Ability to work independently and as a team member.
- Basic knowledge of pharmaceutical industry.
- Goal and results driven.
- Strong process facilitation, problem solving and analytical thinking abilities to make sound business decisions on a day-to-day basis.
- Excellent verbal, written and interpersonal communication skills.
- Clear, articulate and grammatically sound speech and professional manner.
- Strong focus on providing customers with superior support and service.
- Ability to learn, understand and communicate complex information.
- Strong rapport building skills and active listening skills.
- Excellent selling, closing, persuasion and presentation skills.
- Ability to display high levels of initiative, effort and commitment successfully complete projects and assignments.
- Ability to comprehend and communicate complex technical/medical terminology and to maintain the required technical expertise including competitive product knowledge.
- Must be self-motivated and disciplined.
- Strong planning and organizational skills and strong attention to detail.
- Ability to work independently and as a team member.
- Ability to multitask and successfully operate in a fast-paced environment.
- Flexibility and ability to handle multiple tasks simultaneously.
- Ability to work with people at all levels inside and outside of the company.
- Demonstrated technical aptitude and working proficiency at an advanced level in Microsoft Word, Excel, Power Point and Outlook.
- Must be able to successfully complete training and meet training expectations to operate within the parameters of the program.
Scilex is growing rapidly to fill a vacuum that current exists for non-opioid therapeutics in the Pain space. We’re small and nimble, and need aggressive, forward thinkers to help us navigate this journey. Once up to speed, you would have the freedom to innovate and execute without red tape in a collegial, fast-paced environment where performance is noticed and rewarded.
If Marketing is your passion and you have the right initial experience/skill set to build on; if you thrive in the limelight and have opinions you’re willing to back up and sell to stakeholders; and, importantly, if you’re driven to deliver – we’d love to hear from you. And this cuts both ways - we are vested in your success. We want you to be happy here. Scilex feels like it is on the cusp of something…big. Join us, and grow with us.
Scilex offers a competitive salary and a comprehensive benefits package, including full medical (HMO, PPO, HSA, and FSA options), dental, vision, life and disability insurance, company-matching 401(k), 10 paid holidays, flexible PTO, annual bonus and stock options. We are an Equal Opportunity Employer.
Company
SCILEX HOLDING COMPANY (Nasdaq: SCLX, “Scilex”), majority-owned by Sorrento, is dedicated to the development and commercialization of non-opioid pain management products. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.
The company’s lead product ZTlido® (lidocaine topical system) 1.8%, is a branded prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain.
Scilex’s SP-102 (10 mg dexamethasone sodium phosphate viscous gel injection), or SEMDEXA™, for the treatment of Lumbar Radicular Pain has completed enrollment in a Phase III clinical trial and has received Fast Track Status from the FDA. If approved by the FDA, the company expects SP-102 to be the first FDA-approved non-opioid epidural injection to treat lumbosacral radicular pain, or sciatica, with the potential to replace 10 to 11 million off-label epidural steroid injections administered each year in the US.
SCILEX is committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them the most.
Scilex Pharmaceuticals and Semnur Pharmaceuticals are wholly-owned subsidiaries of Scilex Holding Company.
- Website
- https://www.scilexholding.com/
- Phone
- (650) 516-4310
- Location
-
960 San Antonio Road
Palo Alto
California
94303
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert